This Month in Psychopharmacology

Synthetic THC Shows Promise for Agitation Management in Alzheimer’s Patients

A new randomized controlled trial by Rosenberg and colleagues offer...

Read More

NRX-101 Development Expanded to Include TMS for Depression

Treatment resistance is common in major depressive disorder, and tr...

Read More

FDA Approves Cariprazine for Pediatric Schizophrenia and Bipolar I Disorder

The FDA has expanded the indication for cariprazine to include pedi...

Read More

Concurrent Metformin Use Linked to Better Adherence to Antipsychotics

A recent retrospective cohort study examined whether adding metform...

Read More

Preventing PTSD in Deploying Soldiers Using Attention Bias Modification

Efforts to prevent posttraumatic stress disorder (PTSD) before trau...

Read More

Heart Rate, Cholesterol, and Weight Shifts Vary Widely Across Antidepressant Classes

Antidepressants remain among the most prescribed psychotropics worl...

Read More

Cannabidiol Fails to Protect Against Cannabis-Induced Symptoms in Schizophrenia

A new study examined whether cannabidiol could mitigate the acute a...

Read More

Patterns of Cannabis and Alcohol Use for Sleep Initiation in Young Adults

Sleep difficulties are widespread in young adults, with some indivi...

Read More

Starting Benzodiazepines, Antipsychotics in Hospice with Dementia Linked to Increased Mortality

The Medicare hospice benefit was originally designed to care for ca...

Read More

Relapse Criteria in Schizophrenia

Relapse prevention is critical in long-term schizophrenia managemen...

Read More

Novel Benzodiazepines Linked to More Severe Opioid Overdoses

The combination of opioids and benzodiazepines poses a growing chal...

Read More

Brief Cognitive Behavioral Therapy Shows Promise for Suicide Prevention in Military Populations

Suicide attempts among military personnel are notably higher than i...

Read More